Good Response of Scleromyxedema and Dermato-Neuro Syndrome to Treatment With Intravenous Immunoglobulins

Statistics

Case Report

Escleromixedema y síndrome dermato-neuro: buena respuesta al tratamiento con glucocorticoides e inmunoglobulinas endovenosas

I. Bielsa

Corresponding author

ibielsa.germanstrias@gencat.cat

Corresponding author.

, F. Benvenutti, R.M. Guinovart, C. Ferrándiz

Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Badalona, Universitat Autònoma de Barcelona, Barcelona, Spain

Read

12411

Times
was read the article

3112

Total PDF

9299

Total HTML

Share statistics

Article information

ISSN: 15782190
Original language: English

DOI:10.1016/j.adengl.2012.05.001

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 May	33	12	45
2024 April	110	30	140
2024 March	105	26	131
2024 February	114	36	150
2024 January	102	37	139
2023 December	123	25	148
2023 November	111	27	138
2023 October	109	25	134
2023 September	104	39	143
2023 August	69	17	86
2023 July	102	48	150
2023 June	113	42	155
2023 May	109	33	142
2023 April	96	23	119
2023 March	86	44	130
2023 February	66	35	101
2023 January	73	40	113
2022 December	98	58	156
2022 November	48	32	80
2022 October	47	22	69
2022 September	53	51	104
2022 August	66	49	115
2022 July	77	40	117
2022 June	56	30	86
2022 May	80	42	122
2022 April	100	51	151
2022 March	82	64	146
2022 February	64	43	107
2022 January	63	65	128
2021 December	45	50	95
2021 November	67	68	135
2021 October	86	74	160
2021 September	65	44	109
2021 August	88	60	148
2021 July	49	37	86
2021 June	60	43	103
2021 May	80	65	145
2021 April	140	49	189
2021 March	91	44	135
2021 February	81	47	128
2021 January	60	35	95
2020 December	54	26	80
2020 November	48	50	98
2020 October	61	44	105
2020 September	66	47	113
2020 August	36	77	113
2020 July	35	45	80
2020 June	35	45	80
2020 May	28	42	70
2020 April	32	39	71
2020 March	38	28	66
2020 February	1	5	6
2020 January	4	10	14
2019 December	4	4	8
2019 November	4	4	8
2019 October	0	7	7
2019 September	4	6	10
2019 August	4	9	13
2019 July	4	21	25
2019 June	4	12	16
2019 May	3	25	28
2019 April	2	24	26
2019 March	0	10	10
2019 February	2	9	11
2019 January	2	2	4
2018 December	2	9	11
2018 November	2	0	2
2018 October	1	0	1
2018 September	5	0	5
2018 March	15	1	16
2018 February	60	8	68
2018 January	92	9	101
2017 December	92	10	102
2017 November	81	8	89
2017 October	76	5	81
2017 September	74	7	81
2017 August	68	10	78
2017 July	87	8	95
2017 June	103	11	114
2017 May	117	7	124
2017 April	94	10	104
2017 March	124	20	144
2017 February	177	10	187
2017 January	127	7	134
2016 December	79	18	97
2016 November	171	18	189
2016 October	180	34	214
2016 September	247	16	263
2016 August	213	13	226
2016 July	83	20	103
2016 June	11	26	37
2016 May	7	21	28
2016 April	6	2	8
2016 March	7	2	9
2016 February	5	1	6
2016 January	7	1	8
2015 December	10	3	13
2015 November	38	2	40
2015 October	51	1	52
2015 September	43	1	44
2015 August	15	3	18
2015 July	189	10	199
2015 June	123	12	135
2015 May	161	28	189
2015 April	166	24	190
2015 March	188	14	202
2015 February	163	17	180
2015 January	140	16	156
2014 December	109	9	118
2014 November	109	10	119
2014 October	130	26	156
2014 September	96	26	122
2014 August	117	26	143
2014 July	98	17	115
2014 June	147	14	161
2014 May	161	25	186
2014 April	76	6	82
2014 March	85	7	92
2014 February	76	8	84
2014 January	72	6	78
2013 December	65	13	78
2013 November	72	8	80
2013 October	56	7	63
2013 September	44	9	53
2013 August	44	16	60
2013 July	16	30	46
2013 June	14	19	33
2013 May	14	21	35
2013 April	17	32	49
2013 March	21	16	37
2013 February	36	7	43
2013 January	56	10	66
2012 December	25	6	31
2012 November	1	1	2
2012 August	0	1	1

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter